Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Guselkumab
(Tremfya, TREMFYA)		1件: Guselkumab1件: Guselkumab (Tremfya, TREMFYA) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬6件: 37, 41, 96, 97, 161, 269 💬
2Guselkumab 100 MG
(Tremfya, TREMFYA)		1件: Guselkumab1件: Guselkumab (Tremfya, TREMFYA) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 37 💬
3Guselkumab dose 1
(Tremfya, TREMFYA)		1件: Guselkumab1件: Guselkumab (Tremfya, TREMFYA) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬3件: 51, 96, 97 💬
4Guselkumab dose 2
(Tremfya, TREMFYA)		1件: Guselkumab1件: Guselkumab (Tremfya, TREMFYA) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬3件: 51, 96, 97 💬
5Guselkumab dose 3
(Tremfya, TREMFYA)		1件: Guselkumab1件: Guselkumab (Tremfya, TREMFYA) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
6Guselkumab dose 4
(Tremfya, TREMFYA)		1件: Guselkumab1件: Guselkumab (Tremfya, TREMFYA) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
7Guselkumab dose 5
(Tremfya, TREMFYA)		1件: Guselkumab1件: Guselkumab (Tremfya, TREMFYA) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
8Guselkumab intravenous
(Tremfya, TREMFYA)		1件: Guselkumab1件: Guselkumab (Tremfya, TREMFYA) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 97 💬
9Guselkumab subcutaneous
(Tremfya, TREMFYA)		1件: Guselkumab1件: Guselkumab (Tremfya, TREMFYA) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 97 💬
10Tremfya1件: Guselkumab1件: Guselkumab (Tremfya, TREMFYA) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 37 💬